Vaxil Bio Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 30, 2021 at 05:20 pm EDT
Vaxil Bio Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was CAD 209,000 compared to CAD 291,000 a year ago. Net loss was CAD 209,000 compared to CAD 297,000 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. For the half year, operating loss was CAD 467,000 compared to CAD 462,000 a year ago. Net loss was CAD 467,000 compared to CAD 470,000 a year ago. Basic eps - continuing operations was CAD 0 compared to basic loss per share from continuing operations of CAD 0.01 a year ago.